Advisory Committees: FDA Gets Out Of The Redaction Business
This article was originally published in The Rose Sheet
Executive Summary
Panel members’ curricula vitae will now be released without a review and redaction of potentially confidential information; FDA’s policy change is part of a settlement of lawsuit with Public Citizen.